32 LHRH-test, volwassenen

Author(s):  
L. van Bergeijk ◽  
W. I. de Bruin ◽  
C. J. A. Doelman ◽  
R. Groote Veldman ◽  
R. Maatman ◽  
...  
Keyword(s):  
1994 ◽  
Vol 26 (1) ◽  
pp. 61-66 ◽  
Author(s):  
Francesco Aragona ◽  
Roberto Ragazzi ◽  
Giovanni Battista Pozzan ◽  
Raffaele De Caro ◽  
Pietro Franco Munari ◽  
...  
Keyword(s):  

1978 ◽  
Vol 12 (11) ◽  
pp. 1102
Author(s):  
M L BATRINOS ◽  
CH ANOUSAKIS ◽  
SP PITOULIS ◽  
D IOANNOU ◽  
CH PANITSA-FAFFLIA ◽  
...  
Keyword(s):  

2011 ◽  
pp. 139-141
Author(s):  
L. van Bergeijk ◽  
W. I. de Bruin ◽  
C. J. A. Doelman ◽  
R. Groote Veldman ◽  
R. Maatman ◽  
...  
Keyword(s):  

2020 ◽  
Vol 46 (1) ◽  
Author(s):  
Stefano Stagi ◽  
Salvatore De Masi ◽  
Erica Bencini ◽  
Stefania Losi ◽  
Silvia Paci ◽  
...  

Abstract Background The timing of puberty in girls is occurring at an increasingly early age. While a positive family history is recognised as a predisposing factor for early or precocious puberty, the role of environmental factors is not fully understood. Aims of the study To make a retrospective evaluation of the incidence of newly diagnosed central precocious puberty (CPP) and the rate of pubertal progression in previously diagnosed patients during and after the Italian lockdown for COVID-19, comparing data with corresponding data from the previous 5 years. To determine whether body mass index (BMI) and the use of electronic devices increased during lockdown in these patients. Patients and methods The study included 49 females with CPP. We divided the patients into two groups: group 1, patients presenting a newly diagnosed CPP and group 2, patients with previously diagnosed slow progression CPP whose pubertal progression accelerated during or after lockdown. We collected auxological, clinical, endocrinological and radiological data which were compared with data from two corresponding control groups (patients followed by our Unit, March to July 2015–2019). Patients’ families completed a questionnaire to assess differences in the use of electronic devices before and during lockdown. Results Thirty-seven patients presented newly diagnosed CPP (group 1) and 12, with previously diagnosed but untreated slow progression CPP presented an acceleration in the rate of pubertal progression (group 2). The number of new CPP diagnoses was significantly higher than the mean for the same period of the previous 5 years (p < 0.0005). There were no significant differences between patients in group 1 and control group 1 regarding time between appearance of B2 and CPP diagnosis, although group 1 patients had a significantly earlier chronological age at B2, a more advanced Tanner stage at diagnosis (p < 0.005), higher basal LH and E2 levels, higher LH peak after LHRH test (p < 0.05) and increased uterine length (p < 0.005) and ovarian volume (p < 0.0005). The number of patients with previously diagnosed CPP whose pubertal development accelerated was also statistically higher compared to controls (p < 0.0005). In this group, patients’ basal LH (p < 0.05) and E2 levels (p < 0.0005) became more markedly elevated as did the LH peak after LHRH test (p < 0.05). These patients also showed a significantly accelerated progression rate as measured by the Tanner scale (p < 0.0005), uterine length (p < 0.005), and ovarian volume (p < 0.0005). In both group 1 and group 2, BMI increased significantly (p < 0.05) and patients’ families reported an increased use of electronic devices (p < 0.0005). Conclusion Our data show an increased incidence of newly diagnosed CPP and a faster rate of pubertal progression in patients with a previous diagnosis, during and after lockdown compared to previous years. We hypothesize that triggering environmental factors, such as the BMI and the use of electronic devices, were enhanced during lockdown, stressing their possible role in triggering/influencing puberty and its progression. However, more studies are needed to determine which factors were involved and how they interacted.


1981 ◽  
Vol 15 (3) ◽  
pp. 243-246
Author(s):  
DANIELA LARIZZA ◽  
RENATA LORINI ◽  
MARIANGELA CISTERNINO ◽  
A. SALVATONI ◽  
FRANCESCA SEVERI

1993 ◽  
Vol 137 (3) ◽  
pp. 529-532 ◽  
Author(s):  
P. J. Hammond ◽  
K. Talbot ◽  
R. Chapman ◽  
M. A. Ghatei ◽  
S. R. Bloom

ABSTRACT Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) are hypothalamic peptides sharing considerable sequence homology which are postulated to be hypophysiotrophic releasing factors. When infused into man, PACAP has no effect on anterior pituitary hormone levels, while VIP causes a significant increase in circulating prolactin concentrations. However, PACAP has recently been shown to augment the release of LH and FSH in response to LHRH in rat anterior pituitary cell culture. In order to ascertain if either peptide has a similar effect in man, PACAP and VIP were infused at 3·6 pmol/kg per min into six healthy male volunteers, and an LHRH test was performed 30 min after the infusion was commenced. Infusion of PACAP did not alter the gonadotrophin response to LHRH significantly. However, VIP augmented the release of LH significantly, both during the infusion and for 30 min thereafter, although there was no effect on FSH release. Thus VIP, but not PACAP, potentiates the release of LH after LHRH injection in man. Journal of Endocrinology (1993) 137, 529–532


1994 ◽  
Vol 41 (1) ◽  
pp. 10-15 ◽  
Author(s):  
A. Cavallo ◽  
X.H. Zhou
Keyword(s):  

2014 ◽  
Author(s):  
Kun Hu ◽  
Lucinder Kirk ◽  
Karam Sandhu ◽  
Oreoluwa Odubiyi ◽  
Jeremy Kirk ◽  
...  

1985 ◽  
Vol 19 (4) ◽  
pp. 191A-191A
Author(s):  
Gail E Wu Richards ◽  
Anita Cavallo ◽  
Edward R Smith ◽  
Walter J Meyer
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document